| AEREA Y POSTAL EX-IAAC | 2024 | 2.034 | KG | OMEPRAZOL IMPUREZA D, S/M, S/M OMEPRAZOLE IMPURITY D CRS ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO 1 VIAL(S) PER SALES UNIT; 15 MG PER VIAL ( 15 MG = 0.000015 KG) CODIGO: Y0002027 - LOTE: L03.00 | FRANCE | FRANCE | 93.06 |
| AEREA Y POSTAL EX-IAAC | 2024 | 1.177 | KG | nimodipine impurity A, BP, S/M nimodipine impurity A Estándar para análisis en laboratorio presentacion: 2 ML | UNITED KINGDOM | SPAIN | 791.11 |
| AEREA Y POSTAL EX-IAAC | 2024 | 100 | KG | ETHYL4-(8-CHLORO-5,6-DIHYDRO-11H-BENZOL(5,6)CYCLOHEPTA(1,2-b)PYRIDIN-11-YLIDENE)-1-PIPERID ETHYL4-(8-CHLORO-5,6-DIHYDRO-11H-BENZOL(5,6)CYCLOHEPTA(1,2-b)PYRIDIN-11-YLIDENE)-1-PIPERID MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | PANAMA | 19602.6 |
| AEREA Y POSTAL EX-IAAC | 2024 | 14 | KG | 1-BICYCLOHEPTENYL-1-PHENYL-3-PIPERIDINOPROPANOL-1-HYDROCHLORIDE, S/M, S/M 1-BICYCLOHEPTENYL-1-PHENYL-3-PIPERIDINOPROPANOL-1-HYDROCHLORIDE Materia prima para fabricación de medicamentos COMERCIALIZADO EN KILOGRAMO | INDIA | INDIA | 20091.6 |
| AEREA Y POSTAL EX-IAAC | 2024 | 22 | KG | (1-BICYCLOHEPTENYL-1-PHENYL-3-PIPERIDINOPROPANOL-1-HYDROCHLORIDE), S/M, S/M (1-BICYCLOHEPTENYL-1-PHENYL-3-PIPERIDINOPROPANOL-1-HYDROCHLORIDE) MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 31447.9 |
| AEREA Y POSTAL EX-IAAC | 2024 | 15 | KG | 2,3-Bipyridine, 5-chloro-6-methyl-3-(4-(methylsulfonyl)phenyl), S/M, S/M 2,3-Bipyridine, 5-chloro-6-methyl-3-(4-(methylsulfonyl)phenyl) MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 10909.4 |
| AEREA Y POSTAL EX-IAAC | 2024 | 125 | KG | ETHYL4-(8-CHLRO-5,6-DIHYDRO-11H-BENZA[5,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YLIDENE)-1-PIPERIDIN ETHYL4-(8-CHLRO-5,6-DIHYDRO-11H-BENZA[5,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YLIDENE)-1-PIPERIDIN Materia prima para fabricación de medicamentos COMERCIALIZADO EN KIL | INDIA | PANAMA | 24481 |
| AEREA Y POSTAL EX-IAAC | 2024 | 45 | KG | 3-(dimethylcarbamoyloxy)-1methylpyridium bromide, S/M, S/M 3-(dimethylcarbamoyloxy)-1methylpyridium bromide MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KGS | ITALY | FRANCE | 27274 |
| AEREA Y POSTAL EX-IAAC | 2024 | 60 | KG | 3-(DIMETHYLCARBAMOYLOXY), S/M, S/M 3-(DIMETHYLCARBAMOYLOXY)-1METHYLPYRIDIUM BROMIDE MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN KILOGRAMOS BROMURO DE PIRIDOSTIGMINA/TRANSFERENCIA BANCARIA A 120 DIAS DE FECHA DE AWB | ITALY | SWITZERLAND | 36368 |
| MARITIMA DEL CALLAO | 2024 | 500 | KG | 7-chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)-quinoline sulfate, S/M, S/M 7-chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)-quinoline sulfate MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | CHINA | 67776 |
| MARITIMA DEL CALLAO | 2024 | 500 | KG | 6H-PURIN-6-ONE,2-AMINO-,1,9-DIHYDRO-9-[(2-HYDROXYETH OXY)METHYL], S/M, S/M 6H-PURIN-6-ONE,2-AMINO-,1,9-DIHYDRO-9-[(2-HYDROXYETH OXY)METHYL] MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 21790 |
| AEREA Y POSTAL EX-IAAC | 2024 | 200 | KG | 6h-purin-6-one,2-amino-,1,9-dihydro-9-((2-hydroxyeth oxy)methyl), S/M, S/M 6h-purin-6-one,2-amino-,1,9-dihydro-9-((2-hydroxyeth oxy)methyl) MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOGRAMOS | CHINA | CHINA | 8065.68 |